Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
Use this KALV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KALV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KALV SEC filings page. Lician reads the product cache first so this HTML stays unique to Kalvista Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full KALV income, balance, and cash tables.